February 2013 Medtech Fundings

Medtech fundings for the month of February 2013 stand at $403 million so far (bookmark this page to check back during the month, and when you return be sure to refresh your browser).

Top fundings for the month include:

  • $70 million for TearScience, Inc. (ocular surface interferometer and thermal pulsation system for diagnosis and treatment of evaporative dry eye)
  • $30 million for Intersect ENT, Inc. (sinus implants)
  • $27.5 for Cytomedix, Inc. (regenerative medicine therapies in orthopedics and wound care)
  • $27.3 million for BAROnova, Inc. (satiety device for treatment of obesity)
  • $27.0 million for Ivantis, Inc. (microstent for glaucoma treatment)
  • $23 million for CardioKinetix, Inc. (catheter-based treatment for heart failure)
  • $22.2 million for Gynesonics, Inc. (minimally invasive treatment for uterine fibroids)
  • $14.8 million for Sotera Wireless (wireless vital signs monitoring)
  • $13.0 million for EnteroMedica, Inc. (neuroscience treatment of obesity and metabolic disease)

The complete list of filings for the month is shown at link.

Published by

P. Driscoll

Patrick Driscoll founded MedMarket Diligence and has become a leading source of analysis and insight in medical technology markets. He previously co-founded Medtech Insight and was a principal at Medical Data International. He has 25 years of experience assessing current and potential markets for medical technologies.

Leave a Reply